Poop pills? stool transplants may ease immunotherapy side effects

NCT ID NCT04038619

First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times

Summary

This early-stage trial tests whether a stool transplant (FMT) can help cancer patients who develop severe diarrhea or colon inflammation from immune-checkpoint inhibitor drugs. About 40 patients with various cancers will receive the transplant via colonoscopy. The main goal is to see if it is safe and can reduce gut symptoms within two weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
fecal microbiota transplantation (stool transplant)
What this could lead to
If it works, this could offer a new way to manage severe diarrhea and colon inflammation caused by cancer immunotherapy, helping patients stay on their cancer treatment.
What could go wrong
This is a very early Phase 1 trial with only 40 participants, so it is not yet proven. The procedure involves a colonoscopy and carries risks like infection or worsening symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • M D Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.